Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
W.NicollR
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity
[3] Ipamorelin was originally developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of postoperative ileus, but was discontinued due to lack of efficacy
CDMOs are expanding oral solid dosage (OSD) capabilities to support anticipated demand
Si vous tes intress par l'un de nos produits, ou si vous souhaitez discuter d'une commande personnalise, n'hsitez pas nous contacter
US$ 27.83
US$ 21.46
US$ 26.08
US$ 26.48
US$ 21.97
